Belfast City Hospital, Cardiology Centre, Belfast, Northern Ireland, United Kingdom.
Am J Cardiol. 2010 Oct 1;106(7):936-40. doi: 10.1016/j.amjcard.2010.06.002. Epub 2010 Aug 11.
Radial access coronary procedures are associated with fewer access site complications compared to femoral access. There is controversy regarding greater radiation exposure to patient and operator using radial access. We aimed to compare radiation dose during coronary procedures for the 2 access routes and assess the effect of operator experience with radial access on radiation dose. Fluoroscopy time (FT) and dose-area product (DAP) were recorded for all radial access and femoral access procedures during default femoral access, transition phase (femoral access and early radial access), and default radial access. Femoral access cases (n = 848, 412 diagnostic, 436 percutaneous coronary interventions [PCIs]) and radial access cases (n = 965, 459 diagnostic, 506 PCIs) were assessed. For diagnostics, median FT for radial access was longer than for femoral access (4.43 minutes, interquartile range [IQR] 2.55 to 8.18, vs 2.34 minutes, IQR 1.49 to 4.18, p <0.001) and associated with larger DAP (radial access 1,837 μGy·m(2), IQR 1,172 to 2,783, vs femoral access 1,657 μGy·m(2), IQR 1,064 to 2,376, p <0.001). For PCI, FT was longer for radial access (median 12.02 minutes, IQR 7.57 to 17.54, vs femoral access 9.36 minutes, IQR 6.13 to 14.27, p <0.001)-this did not translate into an increased DAP (femoral access median 3,392 μGy·m(2), IQR 2,139 to 5,193, vs radial access 3,682 μGy·m(2), IQR 2,388 to 5,314, p = NS). For diagnostic radial access, FT decreased from the transition phase (n = 134) to the default radial access phase (n = 323, 5.12 minutes, IQR 3.07 to 9.40, vs 4.21 minutes, IQR 2.49 to 7.52, p = 0.03). This was not observed for PCI. In conclusion, transition from femoral access to radial access for diagnostics and PCI increased FT. DAP increased for diagnostic radial access but not PCI compared with femoral access. FTs for radial access diagnostic cases decreased with experience.
经桡动脉入路冠状动脉介入治疗与股动脉入路相比,其血管入路并发症较少。但经桡动脉入路的患者和术者所接受的辐射量较大,目前仍存在争议。我们旨在比较两种入路途径行冠状动脉介入治疗时的辐射剂量,并评估术者经桡动脉入路操作经验对辐射剂量的影响。记录所有经桡动脉和股动脉入路的经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)患者的透视时间(fluoroscopy time,FT)和剂量面积乘积(dose-area product,DAP)。默认股动脉入路、过渡阶段(股动脉入路联合早期经桡动脉入路)和默认经桡动脉入路时,分别评估经股动脉入路(n=848,412 例诊断性,436 例 PCI)和经桡动脉入路(n=965,459 例诊断性,506 例 PCI)患者的情况。对于诊断性检查,经桡动脉入路的 FT 长于股动脉入路(中位数分别为 4.43 分钟 [四分位距 2.558.18]和 2.34 分钟 [1.494.18],p<0.001),且 DAP 更大(桡动脉入路 1837μGy·m(2) [四分位距 11722783],股动脉入路 1657μGy·m(2) [10642376],p<0.001)。对于 PCI,经桡动脉入路的 FT 更长(中位数分别为 12.02 分钟 [7.5717.54]和 9.36 分钟 [6.1314.27],p<0.001)-但 DAP 并未增加(股动脉入路中位数 3392μGy·m(2) [21395193]和 3682μGy·m(2) [23885314],p=NS)。对于诊断性经桡动脉入路,FT 从过渡阶段(n=134)降至默认经桡动脉入路阶段(n=323,5.12 分钟 [3.079.40],4.21 分钟 [2.497.52],p=0.03)。但对于 PCI 则没有观察到这种变化。总之,从股动脉入路到诊断性 PCI 的经桡动脉入路转变增加了 FT。与股动脉入路相比,诊断性经桡动脉入路的 DAP 增加,但 PCI 时则没有增加。经桡动脉入路诊断性病例的 FT 随着经验的增加而降低。